Go to Page # Page of 10
loading

Defining and Capturing Value for Stem Cell Therapies

 Elizabeth Powers
  11th-Apr-2016
Description: The global healthcare landscape is changing: Yesterday- Regulatory approval, Clinical differentiation, Physician marketing, KOLs influencing clinical, Product place in therapy, Price inelasticity; Today- Regulatory + HTA / Reimbursement approval, Value demonstration, Payer marketing, KOLs influencing clinical + payer + reimbursement + health economic, Patient care pathway, Price elasticity (and in the US patient affordability). These changes are driving a sharp debate about value.
Views: 994
Domain: Medical
Category: Biotech/Pharma
Contributing Organization: World Stem Cell Summit
 ‐ More of their Presentations
Contents:
Defining and Capturing
Value for Stem Cell
Therapies

Elizabeth Powers
Senior Principal
December 10, 2015

The global healthcare landscape is changing
Yesterday
Regulatory approval

Regulatory + HTA / Reimbursement
approval

Clinical differentiation

Value demonstration

Physician marketing

Payer marketing

KOLs influencing clinical

KOLs influencing clinical + payer +
reimbursement + health eco ... See more

Recent Presentations

Yoojin Oh
20 September, 2019
...
19 September, 2019
...
18 September, 2019